Niagen Bioscience, Inc. (NAGE) — Revenue

Annual figures by fiscal year, from SEC filings.

2017: $21.20M2018: $31.56M2019: $46.29M2020: $59.26M2021: $67.45M2022: $72.05M2023: $83.57M2024: $99.60M2025: $129.42M$129.42M
2017Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$129.42M+29.9%
2024$99.60M+19.2%
2023$83.57M+16.0%
2022$72.05M+6.8%
2021$67.45M+13.8%
2020$59.26M+28.0%
2019$46.29M+46.7%
2018$31.56M+48.8%
2017$21.20M